TAYLOR LEIGH: Open Payments
NPI 1013399963 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 16 payments from 10 companies in 2025. Trend: 2023 $110 · 2024 $217 · 2025 $889
Consulting: $644Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $665 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| GENZYME CORPORATION | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Organon LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: DUPIXENT, Zoryve, EBGLYSS, SKYRIZI, Sotyktu, ADBRY, Bimzelx, TREMFYA.
Industry payments across MN — which companies pay providers there.
